The revolutionary HeartSmart® continuous cardiac dynamic monitoring (CCDM) by way of empirical physiological formulae (EPF) embedded into an EPROM chip or in any other device with a personal computing platform, permits for haemodynamic monitoring at bedside, see diagram 3. The physiological parameters required to provide the haemodynamic variables are: heart rate, blood pressure, core body temperature degrees Celcius, height (cm) weight (kg) and mean central venous pressure the only parameter that is not non invasive. Caring for shocked septic -sepsis adult patients is a real challenge. The outcome of any interventional procedure to a great extent relies upon quality, simple, robust haemodynamic monitoring to guide fluid resuscitation with the use of vasopressors and or inotropes. Using the Bland-Altman method for comparing two measurement techniques, there was good agreement between measured and calculated Cardiac Index 
INTRODUCTION
Caring for shocked septic -sepsis adult patients is a real challenge. The outcome of any interventional procedure to a great extent relies upon quality, simple, robust haemodynamic monitoring to guide fluid resuscitation with the use of vasopressors and or inotropes. However, the choice of which vasopressor and or inotrope to use in clinical practice is something of guessing or 'Russian Roulett' as to the outcome of such interventional treatment in shocked septic -sepsis adult patients. This unique HeartSmart software permits the effects of pharmaceutical drugs that alter the physiological parameters affecting many haemodynamic variables especially cardiac output and left heart pressures in the heart and lungs. The aim of this study is to see if the methods agree well enough for CCDM to replace the industry gold standard method PACTD, or perhaps to be used interchangeably with it 1 in adult cases of sepsis or septicshock, see Figure 5 . The study meets the requirements of the Helsinki Declaration. A new bedside method of estimating continuous haemodynamic variables through a central venous pressure catheter using standard methods of ECG with blood pressure monitoring is described and validated 1 . This continuous cardiac dynamic monitor CCDM (HeartSmart TM ) is not based upon current mathematical platforms. CCDM uses a unique empirical set of physiological algorithms to derive haemodynamic variables 2, 1 , embedded into a computer software program that can run on any 'app' personal computer or monitor having computing functionality. The Pulmonary Artery Catheter employing the Thermodilution Method (PACTD) is considered as being the standard method of bedside haemodynamic monitoring since the 1970's. There is much controversy concerning the value of PACTD and the proclaimed values of the benefits PACTD can deliver. However, there is almost universal acceptance that PACTD carries a significant risk of complications, morbidity and mortality. [3] [4] [5] [6] [7] [8] . In the healthcare environments the economical requirements to make large financial savings is also a key concern to healthcare providers throughout the world. PACTD is highly invasive and by comparison to alternative systems that can be described as being less invasive than PACTD. Invariably other technologies do require invasive procedures and come with large dedicated monitors that are expensive, unfriendly to use with the associated long learning skill curves. Clinicians are faced with the dilemma that if all these systems were applied to the patient and measurements recorded simultaneously, each technology would give differing haemodynamic values, so the question arises which of these haemodynamic values are reliable 9, 10 . That question can only be answered by close scrutiny of the outliers against the clinical and pathophysiological background, the method employed here. Two teams of practiced physicians took part in analysing the results of this study as to what data should be removed based upon interrogating all the haemodynamic variables, treatments and diagnosis. Both teams agreed that cases 14, 50 and 60 were so obviously wrong due to suspected operator error using the above criteria and were discarded. 19 to name only but a few of many. The Laws of Flow appertaining to the heart and lungs are the work of Stephen Hales 20, 21 , Darcy and Poiseuille 22, 23 again just some of a great number of physiologist and physicists of the past since 1733, who have contributed to our knowledge today. The HeartSmart cardiac index formula, see below, with some 30 subsets are built upon and analogous to the laws of Young, Darcy and Poiseuille, taking those physical expressions and surrogating the component parts within with physiological parameters to produce biophysical expressions. In addition the understanding of the principle of the EBLH the work of Starling, Marey, Bainbridge and Guyton, provides the links to the cardiovascular functions applicable to the 'K' grid that are used to estimate cardiac index from core body temperature in degrees Celscius, CVP and heart rate beats per minute.
HeartSmart Ci expression
Where Q = flow (cardiac index), CVP = pressure, T = temperature at the time of estimating flow, HR 2 = an empirical number for resistance (every heart beat changes the resistance) K = an empirical physiological drive or power constant accounting for viscosity of the blood, compliance and capacitance and elastic stretch of heart fibres etc.
The 
Method
Having received institutional ethical committee approval for this prospective data study, the data came from three general intensive care units, who were taking part in the Department of Health pulmonary artery catheter management study PACMan, administered through the Intensive Care National Audit Research Centre ICNARC at the BMA House in London. Two teams of investigators were involved in this study, those recording the PACTD measurements and those computing the haemodynamic values using HR, BP, T 0 C and CVP. Both teams were blind to each team's results. Every patient or their relatives gave written consent to take part in this double blind study. All subjects in this study would have had a right heart catheterisation using the floatation pulmonary artery catheter as part of their routine observations and or treatment. This study complies with the Helsinki declaration. A full clinical profile of each patient with the diagnosis were admitted into the general intensive care unit (GICU) especially those patients with sepsis or septic shock the criteria for being in this study, the patient data was available to all the investigators. The design of the study was by author being the same as that in other proactive and retrospective clinical studies that had or were taking place simultaneously with this study. The design of the study was based upon the fact that when performing PACTD cardiac output determinations three bolus injections of saline are made. If the results are within 10 % of each other then you can take the average value to be the cardiac output. Usually haemodynamic trends are of most clinical use rather than single measurements, preferably over 24 h period, thus, every 4 h or as and when the patient's circumstances require haemodynamic evaluation. From a statistical analysis perspective repeatability of test methods 95 % agreement the more plots of data the better and more reliable the results. Thus, the design of these heamodynamic studies covers the necessary end points. Those performing the PACTD were experience clinicians used to performing PACTD, were unaware of this study taking place, except one who led the hospital studies. At no time did the author know which hospitals were involved, had no involvement in the selection of recruits into the study or with those investigators of the PAC -Man study. We analysed the data of 60 consenting adult patients admitted and clinically assessed as to the primary and secondary reasons for admission into in the general intensive care units (GICU), the study took place between the years 2002 -2006. All patients were catheterised with PACTD as part of their normal treatment, recording 6 sets of measurements of the PACTD haemodynamic variables giving a total of 360 points of data. The measured physiological parameters of core body temperature in degrees Celsius, systolic and diastolic blood pressure mmHg, heart rate in beats per minute and CVP in mmHg were given to the author. The measured values of Ci, MPAP and MPWP were hidden until the author calculated 360 of each of the variables for Ci, MPAP and MPWP from the raw data, making this a double blind study. Fluid input and output was also recorded. Demographics 28 Females 46.66 %, age range 20 -80 years old the average age being 63.93 years old. Of the 28 patients only 3 10.71 % were not suffering from sepsis or systemic inflammatory response syndrome (SIRS). 32 Males 53.33 %, age range 21 -88 years old having an average age 61.4 years, 12 recruits 37.5 % were not suffering from shock conditions. Of the 60 patients admitted into the study 15 patients 25 % had an uncomplicated haemodynamic assessment. Figures 1 through 6 inclusive below show a comparison of heamodynamic variables measured by the Pulmonary Artery Catheter Thermodilution Method (PACTD) against those haemodynamic variables calculated by the Continuous Cardiac Dynamic Monitoring (CCDMHeartSmart) system -a new less invasive technique using empirical physiological formulae. The differences between the two methods have been plotted against the average of the two measurements to see easily the size of the differences and their distributions around zero. It is also possible to check that the differences are not related to the size of the measurements. The mean difference and limits of agreements are superimposed as three horizontal lines. (Provided differences within the limits of agreements would not be clinically important, the two methods can be used interchangeably.) Three independent consultants in intensive care checked the patient's forms to identify possible measurement recorded errors. Also the author reviewed the data with another two independent consultants. A sensitivity analysis was performed to see how the results changed once observations that were so obviously "wrong" were excluded see legends 1 through 3 inclusive.
RESULTS

The plots in
Legend 1: Cardiac Index (L / mins / m
2 ) There seemed to be no errors so the two analyses are exactly the same. 
Investigation of Outlying values
Invariably in clinical trials questionable data will present itself arising out of technical or operator errors severally or jointly. Such erroneous data can affect the outcome of the study leading to unsatisfactory conclusions being drawn by the investigators and others. The investigators with experienced anaesthetist outside and independent of the investigative teams, agreed on the erroneous recordings operator error of haemodynamic left heart pressures namely the mean pulmonary artery and mean pulmonary artery capillary wedge pressures, that were physiologically wrong. When scrutinising clinical trial data it is necessary that a robust method for discarding erroneous or misleading data is acceptable through a sound scientific process, in order that the reader(s) may readily concur why that outlying data should be omitted, from the results being statistically analysed. We first challenged some of the cardiac index results, whereas in a number of study subjects a set of spurious CI values were recorded that did not follow the trend of the measured values recorded and or estimated by HeartSmart, see can be interrogated by a cardiovascular physiological challenge or analysis as to their clinical reliability or accuracy. For example, if the pulmonary artery catheter thermodilution method gave a hyperdynamic value for cardiac index/output, whilst the remaining haemodynamic values were in the normal range and there are no signs or symptoms indicating that the patient was in shock sepsis or SIRS, then, the conclusion would be in the absence of any other pathophysiological abnormality, that the value of cardiac index / output was wrong and should be ignored or discarded. It is known that the mean pulmonary arterial pressure MPAP is higher than the mean pulmonary artery occlusion (wedge) pressure MPWP, that the MPWP is generally higher than the mean right atrial RAP or central venous pressure CVP. See Diagram 3.
Diagram 4: The PACTD Pressure Waveforms in the Heart
However, it is not uncommon to encounter recordings of these left heart pressures that contradict the haemodynamic physiological possibilities, as demonstrated in this study. Clinicians take into account the two values of resistance, SVR and PVR when considering options of fluid management, in critically ill patients or for patients undergoing major general surgical or medical procedures, where haemodynamic peri-operative optimisation by way of goal directed therapy is desired. However, SVR, PVR with the left heart pressures MPAP and MPAOP (MPWP) are useful parameters when interrogating spurious and or questionable haemodynamic data. Hence, the outlying measurements between the PACTD and CCDM in this study have been scrutinised and challenged using cardiovascular physiological principles and laws combined with clinical expertise. For example, it is known that the pulse rate varies inversely with the blood pressure; i.e., the pulse is slow when the pressure is high; an expression of baroreceptor reflex influences on heart rate, Marey's law. Bainbridge's reflex when fluids are administered a corresponding increase in heart rate occurs. These two physiological reflexes will affect cardiac output or index as well as having an affect on vasoconstriction and dilatation of the blood vessels etc. The outlying value tables between the two methods are contained in the boxes below with the required physiological parameters necessary to perform the challenge to those two sets of results to the right and outside the inner box, see Legends 1 through 3. The Bland -Altman Scattergram Repeatability of test methods for each set of outlying estimations Ci, MPAP and MPWP respectively in each analytical box. The investigators came to the conclusion that the data in study numbers 14, 50, 60 being discarded entirely accounting for 12 sets of paired values or 5 % of the entire study population of 60 paired sets of measurements, see Tables 1 and 2 . list studynum obs mpap hpap diffmpap if diffmpap>16.245 and diffmpap!=. 
+-----------------------------------------+
list studynum obs mpap hpap diffmpap if diffmpap<-13.478 . list studynum obs mpawp hpawp diffmpawp if diffmpawp>7.243 and diffmpawp!=. 
. list studynum obs mpawp hpawp diffmpawp if diffmpawp<-9.867 
DISCUSSION
We live in a turbulent world where disasters can occur at any given moment and where urgent medical aid is required, combined with the problems of the astronomical rise in costs of health care provision, the political climate of cost cutting, the need for robust, simple portable haemodynamic monitoring is key to survival of patients. The use of pharmacuetical drugs in all types of pathologies lies at the very centre of the medical and surgical treatment of patients. However, it is relatively unknown how those drugs maybe interacting on the cardio-dynamics of patients as they carry out daily activities, especially those patients who have long term conditions such as respiratory pathologies, for example, the treatment of pulmonary artery hypertension and the incidence of such is on the increase. There's no method of being able to evaluate the efficacy of a particular drug treatment as to which drug is the most appropriate for that patient or patient group(s). The requirement for each cell in the body to be able to meet an adequate metabolic requirement oxygen supply and demand cannot be overstated, of which many drugs may interfere with especially if those drugs are causing side effects etc. The potential of HeartSmart computer software for use by the Pharmacuetical industry in the development of new drugs, monitoring efficacy and in research as or as educational tool for the medical profession are almost unlimited. HeartSmart computer software is in the final phase of writing a non invasive version(s) paediatric and adult modules, clinically trialled and to regulatory requirements etc. HeartSmart is a system that is easy to use, cheap, reliable with a short learning curve, providing consistent results, that does not require the hospital to spend money on new expensive monitors or get involved with long term contracts for excessively priced consumables, which unfortunately is the position in many NHS Trust Hospitals UK, this situation of mixed opinions and choice of method is likely to continue. HeartSmart CCDM is a computer software program that's not based upon mathematical platforms, whereas other alternative technologies are. Hence, this is a real time disruptive or destructive technology to existing technologies. However, the cardiovascular physiology and physics underpinning the empirical physiological formulae need to be vigorously tested not only against established haemodynamic technologies but its performance in the most serious of clinical situations. Amongst all the controversy of the benefits of haemodynamic monitoring and its usefulness, there is little doubt that haemodynamic monitoring plays a useful role in the fluid management either for the critically ill or those patients undergoing major surgical or medical procedures [23] [24] [25] [26] [27] [28] . In the face of such a controversial subject of any haemodynamic monitoring to assist in assessing cardio-dynamics in the management of fluids, or by optimising blood flow using goal directed therapy, with the all the differential outcomes, the necessity for a system such as HeartSmart-CCDM is a key technology to simply resolve many of the issues of the value of haemodynamic monitoring. The basis of this study had one aim to rigorously evaluate HeartSmart CCDM against the industry 'standard' pulmonary artery catheter thermodilution method PACTD. This aim also raised the question to see if the methods agree well enough for CCDM HeartSmart to replace PAC, or perhaps to be used interchangeably. That question from scrutiny and analysis of the results of these paired set of measurements indicates the answer is in the affirmative. From the data analysed the answer for CI the two methods appear to agree quite well on average, for MPAP the CCDM underestimate the values while for MPWP it seems to overestimate them. The clinical study data also determines from the outliers for the MPAP and MPAOP these are caused by technical and or operator error, because those results are not consistent physiologically or with the clinical diagnosis of the patient see Figure 5 . Therefore, if the general trend is that CCDM truly underestimates the MPAP whilst overestimating the MPWP, such vagaries are unlikely to be of major clinical significance providing that difference is no more than 15 % away from the measured value. Even more so if the results stay within the normal or abnormal bandwidths. Similar results in other prospective and retrospective clinical trials since 1995 where CCDM -HeartSmart has been compared with PACTD would indicate that HeartSmart's performance is comparable with PACTD [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] , HeartSmart-CCDM appears to be an important technological advance in bedside haemodynamic monitoring. However, the issue of the nurses and physcians knowledge and skill in performing haemodynamic measurements using PACTD remains a major issue some high a century later 40, 41 . Hence the need for a simple haemodynamic system that is not so operator dependant, simple and easy to use, and far less costly that can be used on any group of patients routinely, would be of great benefit. But of special importance and usefulness haemodynamic monitoring is the ability to be able to reasonably assess the haemodynamic status of those patients who are suffering from shock by way of sepsis based on SIRS, where aggressive interventional therapy is being administered to the patient by the medical staff [28] [29] [30] . CCDM HeartSmart has to be validated against existing technologies and in particular against the perceived 'standard' the pulmonary artery catheter thermodilution method PACTD. More often than not comparative haemodynamic studies are performed on patients who require ICU support after major surgery, though not necessarily suffering from sepsis or SIRS. In this study 75 % of those admitted into the study were assessed by experienced investigators using clinical judgment with the pathology to confirm that these patients were suffering from sepsis or SIRS. All those recruited into the study had a chest X-Ray to confirm the PACTD was correctly placed in the West Zone of the heart. Because of all the difficulties encountered with PACTD there is a long standing requirement by the profession for a simpler reliable method in order that the nursing and medical staff can get haemodynamic data easily, that will follow trends of treatment against baseline values, and can be understood 28 . This is especially relevant in ICU's where patients are compromised by multiple organ dysfunctions and in many cases this status maybe irreversible. Nevertheless, fluid management it still necessary requirement for the treatment of the critically ill 30, 31, [38] [39] [40] [41] [42] . This study is evidenced based upon the results indicates that the CCDM -HeartSmart could either be a reliable replacement for or interchangeable with PACTD in the general intensive care units etc.
CONCLUSIONS
The CCDM-HeartSmart® computer software module could prove invaluable for optimizing response to fluid replacement and for guiding cardiovascular support in shock septicsepsis patients. This new, simple technology may help to facilitate routine adoption of perioperative optimization of blood flow using early goal-directed therapy.
